90Y-ibritumumab tiuxetan (Zevalin). Hematology Meeting Reports, [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.729. Disponível em: https://journals.pagepress.org/hmr/article/view/729. Acesso em: 7 aug. 2025.